Literature DB >> 3379429

Cerebrospinal fluid neuron-specific enolase is decreased in multi-infarct dementia, but unchanged in Alzheimer's disease.

R Sulkava1, L Viinikka, T Erkinjuntti, R Roine.   

Abstract

Cerebrospinal fluid (CSF) levels of neuron-specific enolase (NSE) were measured in 22 patients with probable Alzheimer's disease and in 35 patients with multi-infarct dementia, and in 15 controls. CSF NSE in patients with Alzheimer's disease did not differ from those in controls. In patients with multi-infarct dementia without recent vascular events CSF NSE was lower than in controls or in Alzheimer patients. This finding is in accord with the prevailing opinion that vascular dementia is caused by multiple infarcts and not by continuous neuronal ischaemia.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3379429      PMCID: PMC1032972          DOI: 10.1136/jnnp.51.4.549

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  14 in total

1.  Multi-infarct dementia. A cause of mental deterioration in the elderly.

Authors:  V C Hachinski; N A Lassen; J Marshall
Journal:  Lancet       Date:  1974-07-27       Impact factor: 79.321

2.  Accelerated ageing or selective neuronal loss as an important cause of dementia?

Authors:  D M Bowen; P White; J A Spillane; M J Goodhardt; G Curzon; P Iwangoff; W Meier-Ruge; A N Davison
Journal:  Lancet       Date:  1979-01-06       Impact factor: 79.321

3.  Accuracy of clinical diagnosis in primary degenerative dementia: correlation with neuropathological findings.

Authors:  R Sulkava; M Haltia; A Paetau; J Wikström; J Palo
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-01       Impact factor: 10.154

4.  Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease.

Authors:  G McKhann; D Drachman; M Folstein; R Katzman; D Price; E M Stadlan
Journal:  Neurology       Date:  1984-07       Impact factor: 9.910

5.  Experimental brain ischemia: neuron-specific enolase level in cerebrospinal fluid as an index of neuronal damage.

Authors:  R Steinberg; C Gueniau; H Scarna; A Keller; M Worcel; J F Pujol
Journal:  J Neurochem       Date:  1984-07       Impact factor: 5.372

6.  Brain endolases as specific markers of neuronal and glial cells.

Authors:  D Schmechel; P J Marangos; A P Zis; M Brightman; F K Goodwin
Journal:  Science       Date:  1978-01-20       Impact factor: 47.728

7.  Cerebrospinal fluid enolase in stroke.

Authors:  E Hay; J A Royds; G A Davies-Jones; N A Lewtas; W R Timperley; C B Taylor
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-07       Impact factor: 10.154

8.  Neuropsychological differentiation between normal aging, Alzheimer's disease and vascular dementia.

Authors:  T Erkinjuntti; R Laaksonen; R Sulkava; R Syrjäläinen; J Palo
Journal:  Acta Neurol Scand       Date:  1986-11       Impact factor: 3.209

9.  Neuron-specific enolase and S-100 protein levels in cerebrospinal fluid of patients with various neurological diseases.

Authors:  K Mokuno; K Kato; K Kawai; Y Matsuoka; T Yanagi; I Sobue
Journal:  J Neurol Sci       Date:  1983 Aug-Sep       Impact factor: 3.181

10.  Neuronal, non-neuronal and hybrid forms of enolase in brain: structural, immunological and functional comparisons.

Authors:  P J Marangos; A P Zis; R L Clark; F K Goodwin
Journal:  Brain Res       Date:  1978-07-07       Impact factor: 3.252

View more
  1 in total

1.  Cerebrospinal Fluid Proteins as Regulators of Beta-amyloid Aggregation and Toxicity.

Authors:  Kayla M Pate; Regina M Murphy
Journal:  Isr J Chem       Date:  2017-01-18       Impact factor: 3.333

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.